Functional assays showed that miR-134 inhibits EMT in NSCLC cells and Forkhead box protein M1 (FOXM1), a potential metastasis promoter, was a direct and functional target of miR-13438. The gene discussed is FOXM1; the disease is non-small cell lung carcinoma.